Treatment algorithms in stage IV melanoma

Keyphrases

• Treatment Algorithm 100%
• Stage IV Melanoma 100%
• Tumor Genotyping 100%
• Vemurafenib 66%
• Advanced Melanoma 66%
• Participation in Clinical Trials 66%
• Therapeutic Algorithm 66%
• KIT Inhibitors 66%
• Tumor 33%
• New Drugs 33%
• New Therapeutics 33%
• Chemotherapy 33%
• Treatment Modalities 33%
• Therapeutic Potential 33%
• Long-term Survival 33%
• Tumor Load 33%
• Kinase Inhibitor 33%
• Melanoma 33%
• Ipilimumab 33%
• Tumor Response 33%
• Treatment Choice 33%
• Previous Treatment 33%
• Conventional Chemotherapy 33%
• Current Therapeutics 33%
• Exon 11 33%
• Salvage Therapy 33%
• Melanoma Patients 33%
• Dabrafenib 33%
• BRAF Inhibitor (BRAFi) 33%
• Anti-CTLA-4 33%
• BRAF-mutant Melanoma 33%
• Molecular Classification 33%
• BRAF Wild Type 33%
• Treatment Goals 33%
• Exon 13 33%
• Long-term Potential 33%
• Subsequent Line 33%
• Expert Forums 33%

Medicine and Dentistry

• Melanoma 100%
• Neoplasm 83%
• Clinical Trial 33%
• Vemurafenib 33%
• Chemotherapy 33%
• Immunotherapy 16%
• Exon 16%
• Long Term Survival 16%
• Phosphotransferase Inhibitor 16%
• Ipilimumab 16%
• Salvage Therapy 16%
• Dabrafenib 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Melanoma 100%
• Neoplasm 83%
• Clinical Trial 33%
• Chemotherapy 33%
• Vemurafenib 33%
• Long Term Survival 16%
• Phosphotransferase Inhibitor 16%
• Ipilimumab 16%
• Immunotherapy 16%
• Dabrafenib 16%
• Cytotoxic T Lymphocyte Antigen 4 16%